127.7%
Est. open job positions.
Loading...

What GoodRx Is Hiring For

Where GoodRx Is Hiring

Is GoodRx Hiring?

GoodRx (GDRX) currently has 12 active job postings, down 33.3% over the past three months. This hiring slowdown can signal cost-cutting, restructuring, or weakening demand. Its headcount is around 1,073, according to LinkedIn data.

With 12 active postings, GoodRx trails industry peers like Teladoc Health (67) and Veeva Systems (847).

Why Hiring Trends Matter for GDRX Stock

Job posting trends are one of the earliest reads on a company’s operational direction: companies often ramp hiring before revenue accelerates and pull back before earnings disappoint. AltIndex feeds GoodRx’s job-posting count into the GDRX AI Score as one of 25+ alternative data signals, weighed alongside web traffic, sentiment, and fundamentals.

For related employment signals, see GoodRx’s headcount (according to LinkedIn data), and employee business outlook (21% positive), and overall employee rating.

Month over Month Job Posts

Aug 2026 14
Jul 2026 14
Jun 2026 19
May 2026 19
Apr 2026 14
Mar 2026 11
Get GDRX alerts in real-time
The moment the job posts trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

GoodRx Job Postings: Frequently Asked Questions

GoodRx currently has 12 active job postings, based on AltIndex’s daily count of its open LinkedIn listings. This is down 33.3% compared with three months ago.

GoodRx appears to be slowing hiring, with job postings down 33.3% over the past three months. Its headcount stands at 1,073, according to LinkedIn data.

No single signal predicts a stock on its own, but hiring is a useful leading indicator: companies tend to add roles when they expect growth and freeze them when they don’t. AltIndex combines GDRX’s job-posting trend with 25+ other signals in the AI Score rather than reading any one signal in isolation.

GoodRx underperforms its industry peers when it comes to Job Posts, ranking in the 1st percentile.

Sign up and get more insights on GoodRx.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.